Nova Scotia Health Authority
Quick facts
| Founded | 2015 |
|---|
Marketed products
- Aggressive Blood Pressure control
- Chloroprocaine Injection · Anesthesia
Chloroprocaine is a local anesthetic that blocks sodium channels in nerve cell membranes, preventing the initiation and conduction of nerve impulses. - Controlled Release Morphine · Pain Management
Morphine binds to opioid receptors in the central and peripheral nervous system to reduce pain perception and provide analgesia. - Fleet Enema
- Mepivacaine Injection · Anesthesia
Mepivacaine is a local anesthetic that blocks sodium channels in nerve cell membranes, preventing the initiation and propagation of nerve impulses. - Prostagladin · Other
- TCA · Psychiatry, Pain Management
TCA inhibits the reuptake of norepinephrine and serotonin in the central nervous system, increasing their synaptic availability.
Phase 3 pipeline
- acetaminophen plus codeine · Pain management
Acetaminophen acts as a non-selective COX inhibitor, while codeine exerts its effects through opioid receptors. - acetaminophen plus ibuprofen · Pain management
Acetaminophen works by inhibiting the production of prostaglandins, which are chemicals that cause pain and fever, while ibuprofen works by inhibiting the enzyme COX-2, which is involved in the production of prostaglandins.
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: